# Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)

> **NCT01300013** · PHASE2 · COMPLETED · sponsor: **Cytokinetics** · enrollment: 614 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Placebo
- **DRUG:** Omecamtiv mecarbil

## Key facts

- **NCT ID:** NCT01300013
- **Lead sponsor:** Cytokinetics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-09
- **Target enrollment:** 614 (ACTUAL)
- **Last updated:** 2021-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01300013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01300013, "Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01300013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*